Evidence map›Paper›PMID 39382328›Full record

ArticlePain2025

Na V 1.8/Na V 1.9 double deletion mildly affects acute pain responses in mice.

Marta Alves-Simões, Laura Teege, Cecilia Tomni, Martha Lürkens, Annika Schmidt, Federico Iseppon, Queensta Millet, Samuel Kühs, Istvan Katona, Joachim Weis and 6 more

Abstract read
In one paragraph

Article in Pain, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Shaping the Action Potential in Dorsal Root and Trigeminal Ganglia Neurons: Relevance to Pain Mechanisms.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Review
  10. Modulation of human dorsal root ganglion neuron firing by the Nav1.8 inhibitor suzetrigine.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Marta Alves-SimõesMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, Gower Street, London, United Kingdom.ORCID 0000-0002-5228-5584
Laura TeegeCenter of Brain, Behavior and Metabolism & Clinic for Anesthesiology and Intensive Care, University of Lübeck, Lübeck, Germany.
Cecilia TomniInstitute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Jena, Germany.
Martha LürkensInstitute for Human Genetics and Genomic Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany.ORCID 0000-0002-6198-8767
Annika SchmidtInstitute for Human Genetics and Genomic Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Federico IsepponMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, Gower Street, London, United Kingdom.
Queensta MilletMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, Gower Street, London, United Kingdom.
Samuel KühsCenter of Brain, Behavior and Metabolism & Clinic for Anesthesiology and Intensive Care, University of Lübeck, Lübeck, Germany.
Istvan KatonaInstitute of Neuropathology, Medical Faculty, RWTH Aachen University, Aachen, Germany.ORCID 0000-0002-0955-8911
Joachim WeisInstitute of Neuropathology, Medical Faculty, RWTH Aachen University, Aachen, Germany.ORCID 0000-0003-3280-6773
Stefan H HeinemannDepartment of Biophysics, Center for Molecular Biomedicine, Friedrich Schiller University Jena and Jena University Hospital, Jena, Germany.ORCID 0000-0002-4144-0251
Christian A HübnerInstitute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Jena, Germany.
John WoodMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, Gower Street, London, United Kingdom.ORCID 0000-0002-9166-8158
Enrico LeipoldCenter of Brain, Behavior and Metabolism & Clinic for Anesthesiology and Intensive Care, University of Lübeck, Lübeck, Germany.ORCID 0000-0002-7666-460
Ingo KurthInstitute for Human Genetics and Genomic Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany.ORCID 0000-0002-5642-8378
Natja HaagInstitute for Human Genetics and Genomic Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany.ORCID 0000-0002-2482-5969

Funding

Deutsche Forschungsgemeinschaft KU1587/10-1Deutsche Forschungsgemeinschaft KU1587/3-1Deutsche Forschungsgemeinschaft KU1587/4-1Deutsche Forschungsgemeinschaft LE2338/3-1Deutsche Forschungsgemeinschaft LE2338/3-2Versus Arthritis 21950Wellcome Trust
6 · The paper itself

Abstract

abstractThe 2 tetrodotoxin-resistant (TTXr) voltage-gated sodium channel subtypes Na V 1.8 and Na V 1.9 are important for peripheral pain signaling. As determinants of sensory neuron excitability, they are essential for the initial transduction of sensory stimuli, the electrogenesis of the action potential, and the release of neurotransmitters from sensory neuron terminals. Na V 1.8 and Na V 1.9, which are encoded by SCN10A and SCN11A , respectively, are predominantly expressed in pain-sensitive (nociceptive) neurons localized in the dorsal root ganglia (DRG) along the spinal cord and in the trigeminal ganglia. Mutations in these genes cause various pain disorders in humans. Gain-of-function missense variants in SCN10A result in small fiber neuropathy, while distinct SCN11A mutations cause, i. a., congenital insensitivity to pain, episodic pain, painful neuropathy, and cold-induced pain. To determine the impact of loss-of-function of both channels, we generated Na V 1.8/Na V 1.9 double knockout (DKO) mice using clustered regularly interspaced short palindromic repeats/Cas-mediated gene editing to achieve simultaneous gene disruption. Successful knockout of both channels was verified by whole-cell recordings demonstrating the absence of Na V 1.8- and Na V 1.9-mediated Na + currents in Na V 1.8/Na V 1.9 DKO DRG neurons. Global RNA sequencing identified significant deregulation of C-LTMR marker genes as well as of pain-modulating neuropeptides in Na V 1.8/Na V 1.9 DKO DRG neurons, which fits to the overall only moderately impaired acute pain behavior observed in DKO mice. Besides addressing the function of both sodium channels in pain perception, we further demonstrate that the null-background is a very valuable tool for investigations on the functional properties of individual human disease-causing variants in Na V 1.8 or Na V 1.9 in their native physiological environment.

Indexed as

Acute PainNAV1.8 Voltage-Gated Sodium ChannelNAV1.9 Voltage-Gated Sodium ChannelAnimalsDisease Models, AnimalGanglia, SpinalMaleMiceMice, Inbred C57BLMice, KnockoutNAV1.6 Voltage-Gated Sodium ChannelNAV1.6 Voltage-Gated Sodium ChannelNAV1.8 Voltage-Gated Sodium ChannelNAV1.9 Voltage-Gated Sodium ChannelScn10a protein, mouseScn11a protein, mouseScn8a protein, mouse

Identifiers

PMID39382328
PMCPMC11921451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.